Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery
Thursday, September 05, 2019Schrdinger today announced a collaboration with AstraZeneca to deploy Schrdingers advanced computing platform to help accelerate drug discovery efforts
Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin
Wednesday, September 04, 2019Cidara Therapeutics Inc and Mundipharma announced today that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of invasive fungal infections Rezafungin is a novel onceweekly echino...
Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity
Wednesday, September 04, 2019Velabs Therapeutics GmbH a biotech company focused on the rapid screening of functional therapeutic antibodies today announces that it has entered into a partnership agreement with alytas therapeutics GmbH alytas to jointly develop modulatory and fun...
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Tuesday, September 03, 2019Valo Therapeutics Limited an immunooncology company developing tumour antigencoated oncolytic viruses as therapeutic vaccines today announced that it has licensed proprietary PeptiENVTM technology from Helsinki University that enables the coating of...
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America
Tuesday, September 03, 2019Helsinn a Swiss pharmaceutical group focused on building quality cancer care products together with Blanver Farmoqumica e Farmacutica SA a Brazilian company focused on innovative products with high quality medicines and active pharmaceutical ingredie...
DarwinHealth announces a scientific collaboration with Celgene on a discovery platform in systems biology
Saturday, August 31, 2019DarwinHealth today announced a multiyear scientific collaboration with Celgene Corporation Celgene to use algorithms based on quantitative systems biology technologies that also underpin the evidence of diagnosis approved by the Reforms on the Improv...
La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)
Friday, August 30, 2019La Jolla Pharmaceutical Company a leader in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases today announced that the European Commi...
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment
Thursday, August 29, 2019Adaptimmune Therapeutics plc a leader in Tcell therapy to treat cancer and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies today announced that they will codevelop nextgener...
European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer
Thursday, August 29, 2019Roche today announced that the European Commission has approved Tecentriq atezolizumab plus chemotherapy Abraxane paclitaxel proteinbound particles for injectable suspension albuminbound nabpaclitaxel for the treatment of adult patients with unresect...
Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers
Wednesday, August 28, 2019Machavert Pharmaceuticals a preclinical stage pharmaceutical company focused on precision medicine cancer therapies announced today that it has obtained a full exclusive license on RAL GTPase RAL inhibitors from the University of Colorado The license...
